PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:28 AM ET

Sponsor Check › Issuer

SB

STELLAR BIOTECHNOLOGIES INC.

Corporation · organized in British Columbia, Canada · formed 2007 · Port Hueneme, CA · formerly CAG CAPITAL INC.

$2.78Mreported sold (max)
20investors (max)
4offerings
5Form D filings
2009–2011filing years
0new, last 12 mo
Follow this issuerConnect me with this sponsorEmail me the full reportLook further ↓

Data last updated Oct 23, 2026, 5:45 PM ET · Latest filing by this issuer Mar 8, 2011 · Courts (RECAP) last checked: Oct 24, 2026, 2:11 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

STELLAR BIOTECHNOLOGIES INC. is a corporation organized in British Columbia, Canada (formed 2007), based in Port Hueneme, CA.

What this means A deal company is usually set up for one investment; its Form D is the notice it files after selling to investors.

It has filed 5 Form D filings (4 originals, 1 amendment) for 4 offerings between Oct 2009 and Mar 2011. The latest filing of each offering reports a combined $3.53M sold of $7.48M offered to 40 investors; industry as reported: industry reported as "Other", biotechnology; latest exemption Rule 506.

What this means A repeat filer — 4 separate raises over about 2 years. Amendments are routine updates (an ongoing raise must update its Form D at least once a year).

Key people as listed: Daniel E. Morse (director), Darrell Brookstein (executive officer and director), Frank R. Oakes (executive officer and director), Harvey S. Wright (director), Kerry Beamish (executive officer) and 11 more.

What this means These are the people the company itself named as running or promoting it. Tap a name to see every other deal they are on.

Reported money out: $201K in finder's fees (latest filing per offering). No sales-compensation recipients are listed.

What this means No broker was paid — the sponsor sold it directly to investors.

Activity: 0 new offerings in the last 12 months; latest amendment Mar 8, 2011; latest filing Mar 8, 2011.

What this means No new raise filed in the past year — this deal company may be done raising, or simply quiet.

Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched STELLAR BIOTECHNOLOGIES INC..

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY), property records (NYC, FL, IL and TX counties) — none found.

What this means Nothing turned up where we looked (4 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 5 public filings for STELLAR BIOTECHNOLOGIES INC. and found 13 differences: Last filing Mar 8, 2011 with 44% of the target sold; Form D filed 21 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

Business registration (state registry / Secretary of State)

State business registry (Secretary of State) 0 records matched to STELLAR BIOTECHNOLOGIES INC.

No Secretary of State record matched in the registries searched. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

What the community is saying

Community search for STELLAR BIOTECHNOLOGIES INC. has not run yet — it is joining a line of 54,782 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:11 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched STELLAR BIOTECHNOLOGIES INC...

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:11 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

No comparisons published

What is compared

No public statement by this issuer has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this issuer yet.

13 differences found between the filings for STELLAR BIOTECHNOLOGIES INC. (compared 5 filings on Oct 24, 2026)

Note · Mar 8, 2011

Last filing Mar 8, 2011 with 44% of the target sold — STELLAR BIOTECHNOLOGIES INC.

STELLAR BIOTECHNOLOGIES INC. (last filing Mar 8, 2011; $2,784,684 sold of $6,395,400). There is no filing in more than two years and the last one reported under half the target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗EDGAR filer page ↗
Sources
Note · Oct 27, 2010 – Nov 17, 2010

Form D filed 21 days after the first sale — STELLAR BIOTECHNOLOGIES INC.

The filing says the first sale was Oct 27, 2010. The Form D was filed Nov 17, 2010 — 21 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 6 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Nov 17, 2010 ↗STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗
Sources
Note · Oct 27, 2010 – Mar 8, 2011

No amendment in the last 12 months on an offering that may still be open — STELLAR BIOTECHNOLOGIES INC. (latest filing Mar 8, 2011)

The latest filing for this offering is dated Mar 8, 2011 (first sale Oct 27, 2010). It reports $81,396 sold of $3,612,238 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D/A · Mar 8, 2011 ↗STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗
Sources
Note · Apr 9, 2010 – Apr 22, 2010

No amendment in the last 12 months on an offering that may still be open — STELLAR BIOTECHNOLOGIES INC. (latest filing Apr 22, 2010)

The latest filing for this offering is dated Apr 22, 2010 (first sale Apr 9, 2010). It reports $587,355 sold of $1,006,894 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Apr 22, 2010 ↗STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗
Sources
Note · Apr 22, 2010 – Nov 17, 2010

Daniel E. Morse's role changed at STELLAR BIOTECHNOLOGIES INC.: executive officer, director → director

The Apr 22, 2010 filing lists Daniel E. Morse as executive officer, director; the Nov 17, 2010 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Apr 22, 2010 ↗Form D · Nov 17, 2010 ↗Daniel E. Morse — PartnerFacts page ↗STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗
Sources
Note · Oct 8, 2009 – Apr 22, 2010

Darrell Brookstein's role changed at STELLAR BIOTECHNOLOGIES INC.: director → executive officer, director

The Oct 8, 2009 filing lists Darrell Brookstein as director; the Apr 22, 2010 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Oct 8, 2009 ↗Form D · Apr 22, 2010 ↗Darrell Brookstein — PartnerFacts page ↗STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗
Sources
Note · Nov 17, 2010 – Mar 8, 2011

Offering amount lowered between filings — STELLAR BIOTECHNOLOGIES INC.

The Nov 17, 2010 filing says $6,395,400 offered; the Mar 8, 2011 Form D/A says $3,612,238.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Form D (earlier) · Nov 17, 2010 ↗Form D/A (later) · Mar 8, 2011 ↗STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗
Sources
Note · Apr 22, 2010 – Nov 17, 2010

Harvey S. Wright is written 2 different ways on the filings

listed as "Harvey Wright" on 2 filings (from Apr 22, 2010), and "Harvey S. Wright" on 2 filings (from Nov 17, 2010).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Apr 22, 2010 ↗Form D · Nov 17, 2010 ↗Harvey S. Wright — PartnerFacts page ↗
Sources
Note · Oct 8, 2009 – Apr 22, 2010

Industry group changed between filings — STELLAR BIOTECHNOLOGIES INC.

"Other" (Oct 8, 2009); then "Biotechnology" (Apr 22, 2010 to Mar 8, 2011).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Oct 8, 2009 ↗Form D · Apr 22, 2010 ↗STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗
Sources
Note · Oct 8, 2009 – Apr 22, 2010

Reported revenue range changed between filings — STELLAR BIOTECHNOLOGIES INC.

"No Revenues" (Oct 8, 2009); then "Decline to Disclose" (Apr 22, 2010).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Oct 8, 2009 ↗Form D · Apr 22, 2010 ↗STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗
Sources
Note · Apr 22, 2010 – Nov 17, 2010

Address moved from Port Hueneme, CA to Burnaby, British Columbia, Canada (as filed: A1) — STELLAR BIOTECHNOLOGIES INC.

The people listed on the Apr 22, 2010 filing give Port Hueneme, CA; on the Nov 17, 2010 filing they give Burnaby, British Columbia, Canada (as filed: A1).

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Apr 22, 2010 ↗Form D · Nov 17, 2010 ↗STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗
Sources
Note · Oct 8, 2009 – Apr 22, 2010

Address moved from Burnaby, British Columbia, Canada (as filed: A1) to Port Hueneme, CA — STELLAR BIOTECHNOLOGIES INC.

The people listed on the Oct 8, 2009 filing give Burnaby, British Columbia, Canada (as filed: A1); on the Apr 22, 2010 filing they give Port Hueneme, CA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Oct 8, 2009 ↗Form D · Apr 22, 2010 ↗STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗
Sources
Note · Oct 8, 2009 – Mar 8, 2011

Issuer used a different name before — STELLAR BIOTECHNOLOGIES INC.

SEC records list prior names for this filer: CAG CAPITAL INC.. The current name on file is "STELLAR BIOTECHNOLOGIES INC.".

What this means A name change is normal, but your documents may show the old name. Match the CIK, not just the name.

EDGAR filer page ↗STELLAR BIOTECHNOLOGIES INC. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

0 of 4 offerings report sales commissions; 1 reports finder's fees totalling $200,931; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 8, 2011 D/A
File 021-150652
$0$200,931 (est.)$0None listed on this filingEDGAR ↗
Apr 22, 2010 D
File 021-141002
$0$0$0None listed on this filingEDGAR ↗
Apr 22, 2010 D
File 021-141003
$0$0$0None listed on this filingEDGAR ↗
Oct 8, 2009 D
File 021-135093
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Property records 0 documents · 0 ownership records · last checked Oct 24, 2026, 10:16 AM ET · NYC and Cook County lookup still to run

0 recorded documents and 0 ownership records matched to STELLAR BIOTECHNOLOGIES INC. in the sources searched.

Not found in sources searched as of Oct 24, 2026, 10:16 AM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Harris County TX (HCAD ownership rolls 2005–2026) — 1,032,426 records, loaded Oct 24, 2026, 8:00 AM ET; Dallas County TX (DCAD ownership rolls 2021–2027) — 285,535 records, loaded Oct 24, 2026, 8:20 AM ET; Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll) — 514,336 records, loaded Oct 24, 2026, 8:25 AM ET; King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published) — 538,619 records, loaded Oct 24, 2026, 8:27 AM ET; Cook County IL (Assessor sale records 1982–2026 + ownership rolls 1999–2026) — 1,263,035 records, loaded Oct 24, 2026, 9:34 AM ET. Still to be looked up for this issuer: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.

Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Harris County TX (ownership only, no deed, mortgage or sale records; HCAD ownership rolls 2005–2026); Dallas County TX (ownership only, no deed, mortgage or sale records; DCAD ownership rolls 2021–2027); Hillsborough County FL (FL DOR 2026 ownership roll + Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026), Miami-Dade County FL (FL DOR 2026 ownership roll), Broward County FL (FL DOR 2026 ownership roll), Palm Beach County FL (FL DOR 2026 ownership roll); King County WA (Assessor sale records 0000-00-00–2026-10-14; no owner-of-record names published); Cook County IL (Assessor sale records 1982–2026 + ownership rolls 1999–2026); also looked up per issuer when its page is viewed. Recorder indexes (party names on deeds, mortgages and liens) in TX, AZ, NV, CA and WA counties and outside the Clerk index in FL, mortgages and liens outside NYC and Hillsborough County, lis pendens and foreclosure notices everywhere, Los Angeles County CA, Clark County NV, New York City bulk pass (not finished; per-issuer lookups only so far), Maricopa County AZ (loader ready; commercial-purpose statement not yet filed), Salt Lake County UT, and all other counties are not covered — not searched. Last refresh by source: NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) Oct 24, 2026, 9:34 AM ET; Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 9:34 AM ET; Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp) Oct 24, 2026, 8:30 AM ET; King County WA Assessor Real Property Sales extract (EXTR_RPSale.csv) Oct 24, 2026, 8:27 AM ET; Florida DOR NAL roll (Palm Beach 60) Oct 24, 2026, 8:25 AM ET; Florida DOR NAL roll (Broward 16) Oct 24, 2026, 8:24 AM ET; Florida DOR NAL roll (Dade 23) Oct 24, 2026, 8:23 AM ET; Florida DOR NAL roll (Hillsborough 39) Oct 24, 2026, 8:21 AM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 24, 2026, 8:20 AM ET; Harris County Appraisal District real_acct.txt Oct 24, 2026, 8:00 AM ET; Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET. NYC and Cook County are also looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 3:30 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.

Offerings (SEC Form D)

Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.

Offerings at a glance — 4 offerings, 5 filings (one row per SEC file number)
File no.Original Form DLatest filingAmendmentsOffered (latest)Sold (latest)Industry (latest)
021-150652Nov 17, 2010 EDGAR ↗Mar 8, 2011 D/A EDGAR ↗1
latest Mar 8, 2011
$3,612,238$81,396Biotechnology
021-141003Apr 22, 2010 EDGAR ↗Apr 22, 2010 D EDGAR ↗0$1,006,894$587,355Biotechnology
021-141002Apr 22, 2010 EDGAR ↗Apr 22, 2010 D EDGAR ↗0$2,784,684$2,784,684Biotechnology
021-135093Oct 8, 2009 EDGAR ↗Oct 8, 2009 D EDGAR ↗0$74,878$74,878Other

Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.

Mar 8, 2011 D/A Biotechnology — $81,396 sold of $3,612,238 · 2 investors EDGAR ↗
FilingForm D/A (amendment) filed Mar 8, 2011 · amends 0001474168-10-000002 ↗
SEC file no. 021-150652 · accession 0001474168-11-000001 · filing 2 of 2 in this offering
Raise progress$81,396 sold of $3,612,238 offered (2%) · $3,530,842 remaining · first sale Oct 27, 2010
Issuer's note: Based on Bank of Canada exchange rate on October 27, 2010 of CDN$1=US0.9690
Filing timingDate of first sale: Oct 27, 2010 · Original Form D filed: Nov 17, 2010 (21 days after first sale) · This amendment (Form D/A) filed: Mar 8, 2011
This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn.
Time since first sale5,842 days (16.0 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year. This filing is an amendment dated Mar 8, 2011. Most recent amendment for this offering in our index: this filing, Mar 8, 2011.
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors2 total · includes 0 non-accredited investors
Exemption claimedRule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c))
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredEquity; Option, warrant or other right to acquire; Security to be acquired upon exercise
Entity detailsOrganized in BRITISH COLUMBIA, CANADA · formed 2007 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryBiotechnology
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $200,931 (est.) · Proceeds to officers, directors, promoters: $0
Issuer's note: Finder's fees may be payable on Canadian residents only. No finders fees are payable on US residents
Signed byKerry Beamish, CFO (Feb 28, 2011)
Changes vs previous filing
  • total offering: $6,395,400 (Nov 17, 2010) → $3,612,238 (Mar 8, 2011)
  • remaining: $6,314,004 (Nov 17, 2010) → $3,530,842 (Mar 8, 2011)
  • finder's fees: $203,025 (Nov 17, 2010) → $200,931 (Mar 8, 2011)
Compared with the D filed Nov 17, 2010 (EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn.
Market contextNot computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Nov 17, 2010 D Biotechnology — $81,396 sold of $6,395,400 · 2 investors EDGAR ↗
FilingForm D filed Nov 17, 2010
SEC file no. 021-150652 · accession 0001474168-10-000002 · filing 1 of 2 in this offering
Raise progress$81,396 sold of $6,395,400 offered (1%) · $6,314,004 remaining · first sale Oct 27, 2010
Issuer's note: Based on Bank of Canada exchange rate on October 27, 2010 of CDN$1=US0.9690
Filing timingDate of first sale: Oct 27, 2010 · Form D filed: Nov 17, 2010 (21 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale5,842 days (16.0 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year. Most recent amendment for this offering in our index: Mar 8, 2011 (EDGAR ↗).
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors2 total · includes 0 non-accredited investors
Exemption claimedRule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c))
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredEquity; Option, warrant or other right to acquire; Security to be acquired upon exercise
Entity detailsOrganized in BRITISH COLUMBIA, CANADA · formed 2007 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryBiotechnology
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $203,025 (est.) · Proceeds to officers, directors, promoters: $0
Issuer's note: Finder's fees may be payable on Canadian residents only. No finders fees are payable on US residents
Signed byKerry Beamish, CFO (Nov 12, 2010)
Market contextNot computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Apr 22, 2010 D Biotechnology — $587,355 sold of $1,006,894 · 20 investors EDGAR ↗
FilingForm D filed Apr 22, 2010
SEC file no. 021-141003 · accession 0001183740-10-000225
Raise progress$587,355 sold of $1,006,894 offered (58%) · $419,539 remaining · first sale Apr 9, 2010
Issuer's note: 13(a) equals the price of the units (2,109,232 units @ C$0.28), plus the aggregate exercise price of the warrants forming part of the units (1,054,616 warrants @ C$.040), converted to US$. There is no guarantee the warrants will be exercised.
Filing timingDate of first sale: Apr 9, 2010 · Form D filed: Apr 22, 2010 (13 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale6,043 days (16.6 years)
Annual amendmentsIssuer reported the offering may last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET).
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors20 total · issuer reported no non-accredited investors
Exemption claimedRule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c))
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredEquity; Option, warrant or other right to acquire; Security to be acquired upon exercise
Entity detailsOrganized in BRITISH COLUMBIA, CANADA · formed 2007 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryBiotechnology
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0
Signed byBENJAMIN CATALANO, DIRECTOR (Apr 22, 2010)
Market contextNot computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Apr 22, 2010 D Biotechnology — $2,784,684 sold of $2,784,684 · 9 investors EDGAR ↗
FilingForm D filed Apr 22, 2010
SEC file no. 021-141002 · accession 0001183740-10-000224
Raise progress$2,784,684 sold of $2,784,684 offered (100%) · $0 remaining · first sale Apr 9, 2010
Issuer's note: Total Offering Amount represents the deemed issuance price for the shares (10,000,000 shares @ CDN$0.28), converted to US dollars based on the average exhange rate on the date of closing, April 9, 2010, of US$1.00=CDN$1.0055.
Filing timingDate of first sale: Apr 9, 2010 · Form D filed: Apr 22, 2010 (13 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale6,043 days (16.6 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET).
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors9 total · issuer reported no non-accredited investors
Exemption claimedRule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c))
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredEquity · business combination transaction
Entity detailsOrganized in BRITISH COLUMBIA, CANADA · formed 2007 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryBiotechnology
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0
Signed byBENJAMIN CATALANO, DIRECTOR (Apr 22, 2010)
Market contextNot computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Oct 8, 2009 D Other — $74,878 sold of $74,878 · 9 investors EDGAR ↗
FilingForm D filed Oct 8, 2009
SEC file no. 021-135093 · accession 0001183740-09-000449
Raise progress$74,878 sold of $74,878 offered (100%) · $0 remaining · first sale Sep 29, 2009
Issuer's note: Total Offering Amount represents the subscription price of the shares (740,000 shares @ CDN$0.11), converted to US dollars based on an exchange rate on the date of closing, September 29, 2009, of US$1.00=CDN$1.0871.
Filing timingDate of first sale: Sep 29, 2009 · Form D filed: Oct 8, 2009 (9 days after first sale)
Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn.
Time since first sale6,235 days (17.1 years)
Annual amendmentsIssuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET).
Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn.
Investors9 total · issuer reported no non-accredited investors
Exemption claimedRule 506 (filed before Sept 2013, when 506 was split into 506(b) and 506(c))
Minimum investment accepted$0 as filed (no minimum reported)
Securities offeredEquity
Entity detailsOrganized in BRITISH COLUMBIA, CANADA · formed 2007 · revenue range: No Revenues (state and year as reported on the issuer's latest filing)
As reported by the issuer on Form D (Items 1–2 and 5).
IndustryOther
Who is paid to sell itNo sales compensation recipients listed on this filing.
Money to insidersSales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0
Signed byBENJAMIN CATALANO, PRESIDENT, CEO AND A DIRECTOR (Oct 6, 2009)
Market contextNot computed — the exemption as filed is Rule 506 before the Sept 2013 split into 506(b) and 506(c) (see Exemption claimed); ranges are computed only for offerings claiming Rule 506(b) or 506(c), compared with the last 5 years of filings.
SourceThis filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET
Amendment history — 1 amendment on this page, each compared with the filing before it in the same offering
Amendment filedFile no.Compared withWhat changed (both values as filed)
Mar 8, 2011 EDGAR ↗021-150652Nov 17, 2010 Dtotal offering: $6,395,400 (Nov 17, 2010) → $3,612,238 (Mar 8, 2011) · remaining: $6,314,004 (Nov 17, 2010) → $3,530,842 (Mar 8, 2011) · finder's fees: $203,025 (Nov 17, 2010) → $200,931 (Mar 8, 2011)

Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Values as filed; no conclusion is drawn.

All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Mar 8, 2011. Industry as reported, by offering: Previous offerings: Other (2009). Latest offering: Biotechnology (2010; most recent Nov 17, 2010).

Key people 11

Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.

NameRelationshipAddress stateOn filings (first → last)Also listed on
DM Daniel E. Morse
also filed as Daniel E Morse
Executive Officer, DirectorCAApr 22, 2010 → Mar 8, 2011
on 4 of 5 filings
listed on the latest filing
1 other issuer
DB Darrell BrooksteinDirector, Executive OfficerCAOct 8, 2009 → Mar 8, 2011
on 5 of 5 filings
listed on the latest filing
2 other issuers
FO Frank R. Oakes
also filed as Frank R Oakes
Executive Officer, DirectorCAApr 22, 2010 → Mar 8, 2011
on 4 of 5 filings
listed on the latest filing
1 other issuer
HW Harvey S. Wright
also filed as Harvey Wright
DirectorIDApr 22, 2010 → Mar 8, 2011
on 4 of 5 filings
listed on the latest filing
—
KB Kerry BeamishExecutive OfficerBritish Columbia, Canada (as filed: A1)Nov 17, 2010 → Mar 8, 2011
on 2 of 5 filings
listed on the latest filing
—
MG Malcolm GefterDirectorMANov 17, 2010 → Mar 8, 2011
on 2 of 5 filings
listed on the latest filing
1 other issuer
WC W. Benjamin CatalanoDirectorCAApr 22, 2010 → Mar 8, 2011
on 4 of 5 filings
listed on the latest filing
2 other issuers
KB Kerin BeamishExecutive OfficerCAApr 22, 2010
on 2 of 5 filings
not listed on the latest filing (Mar 8, 2011)
—
AJ Alan G JIExecutive Officer, DirectorBritish Columbia, Canada (as filed: A1)Oct 8, 2009
on 1 of 5 filings
not listed on the latest filing (Mar 8, 2011)
—
BC Benjamin CatalanoExecutive Officer, DirectorBritish Columbia, Canada (as filed: A1)Oct 8, 2009
on 1 of 5 filings
not listed on the latest filing (Mar 8, 2011)
—
MW Martin JC WoodwardDirectorBritish Columbia, Canada (as filed: A1)Oct 8, 2009
on 1 of 5 filings
not listed on the latest filing (Mar 8, 2011)
—

Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (none on this issuer); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗. Middle names: the SEC Form D data set (RELATEDPERSONS.tsv) repeats the previous person's middle name into later rows of the same filing; where that happened PartnerFacts shows the name without the repeated middle name and keeps the data-set spelling on record (DARRELL G BROOKSTEIN; DARRELL E BROOKSTEIN; Darrell E. Brookstein; HARVEY E WRIGHT; Kerry Benjamin Beamish; Malcolm Benjamin Gefter; W. BENJAMIN E CATALANO; KERIN E BEAMISH) — the filing on EDGAR is the source.

Connections

Other issuers listing the same people:

Shared address: this business address appears on no other issuer's filings in our index. As of Oct 23, 2026, 5:45 PM ET.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Adviser registration (Form ADV)

Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched STELLAR BIOTECHNOLOGIES INC..

Meta advertising

No Meta Pixel ids or Facebook / Instagram page links on file for STELLAR BIOTECHNOLOGIES INC. as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.

Public profiles

Public profiles official links and public statements, each with its source and date

No website or social profile named in STELLAR BIOTECHNOLOGIES INC.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #353,566 of 374,652 in line (1,386 issuers searched so far).

Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.

Entity standing: not checked (no official programmatic source for CA yet).

Export this report as PDF (all source links + data timestamp) · Premium

Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".

Corrections log

No corrections have been requested for this page.

Filing-to-filing changes are in Amendment history above.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Claim this profile · Facts policy

Email me the full report

The complete public-record profile for STELLAR BIOTECHNOLOGIES INC., plus the weekly new-filings list.

What do you want to do?

Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.

Request a correction

Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).

Sponsor response

Sponsors may add a sourced explanation next to any fact on this page. Reviewed before publishing; never edits the public record.

Claim this profile (sponsors)

Free. Get the "Claimed by sponsor" chip and a confirmed contact for corrections. Claiming never changes the public-record section.

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Port Hueneme, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn companies ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗OpenCorporates ↗